Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Arcadis reports transactions under its current share buyback program
-
Innofactor Plc: Managers’ Transactions
-
New final terms for Euro Medium Term Note Programme - Nykredit Realkredit A/S
-
Bank of Åland Plc: Managers' Transactions (Eurell)
-
Tonner Drones Signs First Contract For Its Consultancy Business
-
Exor Press Release - Periodic Report on the Buyback Program
-
CBDC Transaction Volume to Reach 7.8 Billion by 2031, Juniper Research Finds
-
AAVantgarde Founder and Chief Scientific Officer, Professor Alberto Auricchio, is elected as President of the European Society of Gene and Cell Therapy
-
FLSmidth signs strategic cooperation agreement with Enter Engineering for the delivery of core mineral processing equipment for a new copper concentrator production line at Almalyk MMC in Uzbekistan
-
Bank of Åland Plc: Managers' Transactions (Wiklöf)
-
NBPE Announces 2024 ZDP Repayment Date
-
Inside information: CEO Mikko Koskimies steps down from his role due to serious illness
-
Miscellaneous
-
ViaNautis Bio Signs Strategic Collaboration Agreement with Lilly to leverage its polyNaut® platform to develop novel products delivering genetic medicines
-
Invitation to Enefit Green investor webinars presenting Q3 2024 interim results
-
Transaction in Own Shares
-
Subsea7 share repurchases
-
UAB Partnerystės projektai keturi Notes partial redemption and interest payment
-
JCDecaux has decided not to pursue the acquisition of Clear Channel’s business in Spain
-
Oma Savings Bank Plc’s Interim Report 1.1.-30.9.2024: The business developed as expected and the risk management action plan is progressing
-
KPN delivers organic growth in all segments and confirms guidance
-
Exosens: Continued strong growth momentum and significantly improved adjusted gross margin in 9M 2024
-
BGHL (GBP): NAV(s)
-
BGHL (EUR): NAV(s)
-
Sampo plc’s share buybacks 25 October 2024
-
BAWAG Group publishes Q3 2024 results: Net profit € 178 million and RoTCE 24.0%
-
Philips delivers strong margin improvement; flat comparable sales due to further deteriorated demand in China; growth in rest of world
-
Start of Day Message
-
BioSenic provides third quarter 2024 Business Update
-
Ad Hoc Announcement: Board of Directors of GAM Holding AG announces terms of its rights offering
-
Mowi ASA (OSE:MOWI): Presentation of Q3 2024 results 6 November 2024 at 08:00 (CET)
-
DeFi project 1inch partners with the Bruce Lee Family Company
-
CORXEL and LENZ Therapeutics Announce Positive Topline Data from China Phase 3 Presbyopia Trial of LNZ100
-
Business Headline Is Looking For The Next Funding Round, To Open Their First Office In Noida By 2025
-
Longeveron® Presents Lomecel-B™ Long-term Transplant-free Survival Data in Hypoplastic Left Heart Syndrome (HLHS) at the Congenital Heart Surgeons’ Society (CHSS) 51st Annual Meeting
-
Phathom Pharmaceuticals to Present VOQUEZNA® Data at the American College of Gastroenterology (ACG) 2024 Annual Meeting
-
DEADLINE THIS WEEK: Berger Montague Advises Super Micro Computer (NASDAQ: SMCI) Investors to Contact the Firm Before October 29, 2024
-
eXp Realty Announces Winners of Hackathon at eXpcon Miami
-
Positive Long-term Outcomes with HeartFlow FFRCT and Plaque Analysis Demonstrated in ADVANCE-DK Registry at TCT 2024
-
ECARX Powers Global Launch of the smart #5 Premium Mid-Size SUV
-
X Empire’s Token Landed on Bybit with a Splash: Bybit Breaks Airdrop Records and Offers 920,000,000 X in Rewards
-
Biogen Presents Positive Results from Phase 2 IGNAZ Study of Felzartamab in IgA Nephropathy at American Society of Nephrology (ASN) Kidney Week 2024
-
Novartis oral Fabhalta® (iptacopan) sustained clinically meaningful results at one year in Phase III C3 glomerulopathy (C3G) trial
-
Vera Therapeutics Announces 96-week eGFR Stabilization in ORIGIN Phase 2b Study of Atacicept in IgAN in a Late-Breaking Oral Presentation at the American Society of Nephrology Kidney Week 2024
-
Celldex Announces Barzolvolimab Met All Primary and Secondary Endpoints with High Statistical Significance in Positive Phase 2 Study in Chronic Inducible Urticaria
-
WEBTOON (NASDAQ: WBTN) Deadline Approaching: Berger Montague Advises Investors of Deadline in Securities Fraud Lawsuit
-
River Capital Limited Backs eVTOL Market to Propel Future Innovations in Urban Air Mobility
-
Pivotal VALIANT Results Presented at Kidney Week Highlight Strength of Pegcetacoplan Treatment Effect in Patients with C3G / Primary IC-MPGN
-
Exhale Wellness Announces Limited-Time Halloween Discount on THC Gummies
-
ICONS Highlights Rally to Support University of Nevada Reno Women’s Volleyball Team in Stand for Justice and Fair Play on the Court

